Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Safety and Effects of Tulisokibart for Patients with Moderate to Severe Crohn's Disease
FranceStudy on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
FranceStudy on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease
FranceStudy on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis
FranceStudy of Elafibranor in Adults with Primary Biliary Cholangitis Who Don't Respond Well to or Cannot Tolerate Ursodeoxycholic Acid Treatment
FranceStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
FranceStudy of Tulisokibart for Patients with Moderately to Severely Active Ulcerative Colitis
FranceStudy on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer
FranceStudy to Evaluate Plozasiran for Adults with High Triglycerides
FranceStudy on the Effectiveness and Safety of Polatuzumab Vedotin, Rituximab, and CHP in Patients with Untreated Diffuse Large B-Cell Lymphoma
FranceStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
FranceStudy of Vutrisiran for Patients with Transthyretin Amyloidosis and Heart Disease
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
